APA (7th ed.) Citation

Vergis, N., Patel, V., Bogdanowicz, K., Czyzewska-Khan, J., Fiorentino, F., Day, E., . . . Thursz, M. (2021). IL-1 Signal Inhibition In Alcoholic Hepatitis (ISAIAH): A study protocol for a multicentre, randomised, placebo-controlled trial to explore the potential benefits of canakinumab in the treatment of alcoholic hepatitis. BMC.

Chicago Style (17th ed.) Citation

Vergis, N., et al. IL-1 Signal Inhibition In Alcoholic Hepatitis (ISAIAH): A Study Protocol for a Multicentre, Randomised, Placebo-controlled Trial to Explore the Potential Benefits of Canakinumab in the Treatment of Alcoholic Hepatitis. BMC, 2021.

MLA (8th ed.) Citation

Vergis, N., et al. IL-1 Signal Inhibition In Alcoholic Hepatitis (ISAIAH): A Study Protocol for a Multicentre, Randomised, Placebo-controlled Trial to Explore the Potential Benefits of Canakinumab in the Treatment of Alcoholic Hepatitis. BMC, 2021.